Fonte: Crystal Growth and Design. Unidade: IFSC
Assuntos: PLANEJAMENTO DE FÁRMACOS, CRISTALOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Luan F. et al. Reducing the hygroscopicity of the anti-tuberculosis drug (s,s)-ethambutol using multicomponent crystal forms. Crystal Growth and Design, v. 17, n. 5, p. 2622-2630, 2017Tradução . . Disponível em: https://doi.org/10.1021/acs.cgd.7b00144. Acesso em: 11 nov. 2025.APA
Diniz, L. F., Carvalho Junior, P. S., Melo, C. C., & Ellena, J. (2017). Reducing the hygroscopicity of the anti-tuberculosis drug (s,s)-ethambutol using multicomponent crystal forms. Crystal Growth and Design, 17( 5), 2622-2630. doi:10.1021/acs.cgd.7b00144NLM
Diniz LF, Carvalho Junior PS, Melo CC, Ellena J. Reducing the hygroscopicity of the anti-tuberculosis drug (s,s)-ethambutol using multicomponent crystal forms [Internet]. Crystal Growth and Design. 2017 ; 17( 5): 2622-2630.[citado 2025 nov. 11 ] Available from: https://doi.org/10.1021/acs.cgd.7b00144Vancouver
Diniz LF, Carvalho Junior PS, Melo CC, Ellena J. Reducing the hygroscopicity of the anti-tuberculosis drug (s,s)-ethambutol using multicomponent crystal forms [Internet]. Crystal Growth and Design. 2017 ; 17( 5): 2622-2630.[citado 2025 nov. 11 ] Available from: https://doi.org/10.1021/acs.cgd.7b00144
